Compared to baseline, SP-D had increased in RA patients at four years (893 ng/ml [810; 1013] vs. 693 ng/ml [649; 770], P < 0.001) even when adjusting for gender, age and smoking status (p < 0.001). Here, SFTPD is linked to rheumatoid arthritis.